| Filed On | Filing |
|---|---|
| 22 Feb 2024 | 15-12G |
| 14 Feb 2024 | SC 13G/A |
| 14 Feb 2024 | SC 13G/A |
| 13 Feb 2024 | SCHEDULE 13G/A |
| 12 Feb 2024 |
Form 4: Mitchell Dean J, Director
Returned 103,000 shares to the issuer · Disposed of 13,090 Restricted Stock Unit (Disposition to Issuer) · Disposed of 142,667 Deferred Share Unit (Disposition to Issuer) · 1 more |
| 12 Feb 2024 |
Form 4: Peterson Kristine, Director
Disposed of 13,090 Restricted Stock Unit (Disposition to Issuer) · Disposed of 74,954 Deferred Share Unit (Disposition to Issuer) · Disposed of 208,597 Stock Option (Right to Buy) (Disposition to Issuer) |
| 12 Feb 2024 |
Form 4: Thackray Helen M., Director
Returned 3,074 shares to the issuer · Disposed of 13,090 Restricted Stock Unit (Disposition to Issuer) · Disposed of 40,932 Deferred Share Unit (Disposition to Issuer) · 1 more |
| 12 Feb 2024 |
Form 4: Enyedy Mark J, Director
Returned 584,397 shares to the issuer · Disposed of 242,823 Restricted Stock Unit (Disposition to Issuer) · Disposed of 4,244,275 Stock Option (Right to Buy) (Disposition to Issuer) |
| 12 Feb 2024 |
Form 4: Wallace Richard John, Director
Returned 10,000 shares to the issuer · Disposed of 13,090 Restricted Stock Unit (Disposition to Issuer) · Disposed of 102,326 Deferred Share Unit (Disposition to Issuer) · 1 more |
| 12 Feb 2024 |
Form 4: Coen Stacy Ann, SVP & CHIEF BUSINESS OFFICER
Returned 73,274 shares to the issuer · Disposed of 777,270 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 67,993 Restricted Stock Unit (Disposition to Issuer) |
| 12 Feb 2024 |
Form 4: Lentini Renee, VP & PRIN ACCTG OFFICER
Returned 14,723 shares to the issuer · Disposed of 49,509 Restricted Stock Unit (Disposition to Issuer) · Disposed of 157,121 Stock Option (Right to Buy) (Disposition to Issuer) |
| 12 Feb 2024 |
Form 4: Goldberg Mark Alan, Director
Returned 60,720 shares to the issuer · Disposed of 13,090 Restricted Stock Unit (Disposition to Issuer) · Disposed of 160,350 Deferred Share Unit (Disposition to Issuer) · 1 more |
| 12 Feb 2024 |
Form 4: Arbuckle Stuart A, Director
Returned 5,381 shares to the issuer · Disposed of 13,090 Restricted Stock Unit (Disposition to Issuer) · Disposed of 63,000 Deferred Share Unit (Disposition to Issuer) · 1 more |
| 12 Feb 2024 |
Form 4: Wingrove Theresa, SVP OF REGULATORY AFFAIRS
Returned 21,039 shares to the issuer · Disposed of 588,881 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 69,724 Restricted Stock Unit (Disposition to Issuer) |
| 12 Feb 2024 |
Form 4: Mccluski Stephen C, Director
Disposed of 13,090 Restricted Stock Unit (Disposition to Issuer) · Disposed of 105,458 Deferred Share Unit (Disposition to Issuer) · Disposed of 228,597 Stock Option (Right to Buy) (Disposition to Issuer) |
| 12 Feb 2024 |
Form 4: McCain Tracey L, Director
Disposed of 13,090 Restricted Stock Unit (Disposition to Issuer) · Disposed of 50,303 Deferred Share Unit (Disposition to Issuer) · Disposed of 89,153 Stock Option (right to buy) (Disposition to Issuer) |
| 12 Feb 2024 |
Form 4: Kalofonos Isabel, SVP & CHIEF COMMERCIAL OFFICER
Disposed of 284,250 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 66,833 Restricted Stock Unit (Disposition to Issuer) |
| 12 Feb 2024 |
Form 4: White Lauren, SVP, CFO AND PFO
Acquired 295,975 Stock Option (Right to Buy) (Disposition to Issuer) · Acquired 71,144 Restricted Stock Unit (Disposition to Issuer) |
| 12 Feb 2024 |
Form 4: Char Daniel, SVP & CHIEF LEGAL OFFICER
Returned 1,000 shares to the issuer · Disposed of 400,000 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 22,825 Restricted Stock Unit (Disposition to Issuer) |
| 12 Feb 2024 |
Form 4: Vasconcelles Michael, EVP R&D & MEDICAL AFFAIRS
Returned 1,327 shares to the issuer · Disposed of 960,000 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 50,515 Restricted Stock Unit (Disposition to Issuer) |
Loading...
